
3 Dividend Stocks for March 2026
These dividend-growth stocks are attractive today.
Loading news...

These dividend-growth stocks are attractive today.

GALWAY, Ireland, March 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that Thierry Piéton, Medtronic executive vice president and chief financial officer, will participate in fireside chats at the following investor conferences: Barclays 28th Annual Global Healthcare Conference Tuesday, March 10, 2026, at 10:30 a.m. a.m. EST (9:30a.m.

MDT launches MiniMed Go Smart MDI with the Simplera sensor in Europe, advancing connected insulin care as the Diabetes unit's IPO plans progress.

Bahl and Gaynor Inc. lowered its position in shares of Medtronic PLC (NYSE: MDT) by 13.3% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 41,605 shares of the medical technology company's stock after selling 6,404 shares during the quarter. Bahl and Gaynor Inc.'s holdings

111 Capital acquired a new stake in Medtronic PLC (NYSE: MDT) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 12,036 shares of the medical technology company's stock, valued at approximately $1,146,000. Several other hedge funds also recently bought and sold shares

Intuitive Surgical has been growing strongly as it builds out its surgical robotics business. This medical device competitor has just launched its own surgical robot in the United States.

Medtronic has been hiking its dividend for nearly 50 consecutive years. It's spinning off its diabetes division to focus on faster-growing businesses.

Artisan Partners Limited Partnership lifted its stake in Medtronic PLC (NYSE: MDT) by 2.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,234,550 shares of the medical technology company's stock after buying an additional 31,314 shares during the period.

Medtronic PLC (NYSE: MDT - Get Free Report) EVP Harry Skip Kiil sold 52,524 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $97.71, for a total transaction of $5,132,120.04. Following the completion of the sale, the executive vice president owned 32,768 shares in

DNB Asset Management AS lessened its stake in shares of Medtronic PLC (NYSE: MDT) by 58.6% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 374,446 shares of the medical technology company's stock after selling 529,036 shares during the quarter. DNB Asset Management

Andra AP fonden lifted its stake in shares of Medtronic PLC (NYSE: MDT) by 412.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 321,129 shares of the medical technology company's stock after purchasing an additional 258,500 shares during

Medtronic PLC (NYSE: MDT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the twenty-six brokerages that are presently covering the stock, MarketBeat.com reports. Ten equities research analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong buy recommendation to

Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the commercial launch in Europe of the MiniMed Go™ Smart MDI system with the Simplera™ sensor. The system, which is the first and only solution to integrate data from the InPen™ smart insulin pen and the Simplera™ sensor into a single mobile app, is designed to help people who use multiple daily injections (MDI) to better control their diabetes.

GALWAY, Ireland, Feb. 24, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial public offering (IPO) of 28,000,000 shares of its common stock. The proposed offering is part of Medtronic's previously announced plan to separate its Diabetes business into an independent public company.

Medtronic's diabetes business MiniMed Group said on Tuesday it was aiming to raise as much as $784 million in its initial public offering in the United States.

Dakota Wealth Management grew its position in Medtronic PLC (NYSE: MDT) by 109.5% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 156,715 shares of the medical technology company's stock after purchasing an additional 81,896 shares during the period.

Clearstead Advisors LLC lifted its position in shares of Medtronic PLC (NYSE: MDT) by 14.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 44,117 shares of the medical technology company's stock after acquiring an additional 5,458 shares during the

Medtronic is one of the world's largest medical device companies. Its dividend streak speaks volumes about the strength of its business.

It isn't easy to find a healthcare company that regularly pays a generous dividend. It's even harder to find one with an annual raise streak approaching 50 years.

Bleakley Financial Group LLC increased its position in Medtronic PLC (NYSE: MDT) by 17.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 87,313 shares of the medical technology company's stock after purchasing an additional 13,177 shares during